OFFICE FOR RESEACH PROCEDURE. Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records

Similar documents
Standard Operating Procedures

Unofficial copy not valid

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

TRAINING REQUIREMENTS FOR RESEARCH STAFF, INCLUDING GOOD CLINICAL PRACTICE (GCP)

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

STANDARD OPERATING PROCEDURE

Standard Operating Procedures (SOP) Research and Development Office

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Standard Operating Procedure. Essential Documents: Setting Up a Trial Master File. SOP effective: 19 February 2016 Review date: 19 February 2018

Standard Operating Procedure (SOP) Research and Development Office

Trial Management: Trial Master Files and Investigator Site Files

Standard Operating Procedure (SOP) Research and Development Office

STANDARD OPERATING PROCEDURE SOP 325

GCP: Investigator Responsibilities. Susan Tebbs Nicola Kaganson

STANDARD OPERATING PROCEDURE 24. Training Records

Auditing of Clinical Trials

Research Governance Framework 2 nd Edition, Medicine for Human Use (Clinical Trial) Regulations 2004

Clinical Trial Readiness Checklist October 2014

Standard Operating Procedures (SOP) Research and Development Office

Research Staff Training

Investigator Site File Standard Operating Procedure (SOP)

Roles & Responsibilities of Investigator & IRB

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Standard Operating Procedures

1. INTRODUCTION 2. SCOPE 3. PROCESS

Standard Operating Procedure (SOP) for Reporting Serious Breaches in Clinical Research

Trial set-up, conduct and Trial Master File for HEY-sponsored CTIMPs

Joint R&D Support Office SOP S-2011 UHL

Document Title: Informed Consent for Research Studies

Document Title: GCP Training for Research Staff. Document Number: SOP 005

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

STANDARD OPERATING PROCEDURE SOP 715. Principles of Clinical Research Laboratory Practice

Document Title: Investigator Site File. Document Number: 019

Visitors report. Contents. Doctorate in Health Psychology (Dpsych) Full time Part time. Programme name. Mode of delivery. Date of visit 7 8 June 2012

Standard Operating Procedure (SOP) for Reporting Urgent Safety Measures in Clinical Research

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Informed Consent SOP Number: 25 Version Number: 6.0 Effective Date: 1 st September 2017 Review Date: 1 st September 2019

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

STANDARD OPERATING PROCEDURE

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

Standard Operating Procedure Research Governance

Clinical Study Risk Assessment

Human Research Governance Review Policy

How/Where Can we Convey the Notion that Clinical Trials are Relevant for Everyone and Thereby Enhance Delivery of Patient Care?

managing or activities.

Standard Operating Procedure (SOP)

STANDARD OPERATING PROCEDURE

MHRA Findings Dissemination Joint Office Launch Jan Presented by: Carolyn Maloney UHL R&D Manager

Good Clinical Practice: A Ground Level View

Corporate. Research Governance Policy. Document Control Summary

SECTION 2: REGISTER YOUR ICU

Marie-Claire Rickard, RG and GCP Manager Jimena Lovos, Quality Assurance Manager Elizabeth Clough, R&D Governance Operations Manager

Clinical Supervision Policy

A Screen patients G Review/Accountability/Sign off Form 2:Dosing Log M IMP Supply/Management. SAE clinical review/causality Assessment and Sign off

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

Joint Statement on the Application of Good Clinical Practice to Training for Researchers

Site Qualification and Training (SQT) INFORMATION AND GUIDANCE SHEET FOR SITE SIGNATURE AND DELEGATION OF RESPONSIBILITIES LOG

GCP INSPECTION CHECKLIST

Version Number: 003. On: September 2017 Review Date: September 2020 Distribution: Essential Reading for: Information for: Page 1 of 13

Independent prescribing conversion programme. De Montfort University Report of a reaccreditation event May 2017

NHS RESEARCH PASSPORT POLICY AND PROCEDURE

Construction Industry Training Board Appendix I - January 2018 version 1

The Alfred Streamlining Ethical Review Guide. Overview Page 1. The Review Schemes - A description the two different schemes Page 2

Site Closedown Checklist for UoL Sponsored CTIMP Studies

STH Researcher. Recording of research information in patient case notes

Name. Full time. April Contents

Document Title: Document Number:

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

Ethics Committee Composition Roles & Responsibilities. Dr Girish Dayma Dr Sanjay Juvekar KEM Hospital Research Centre Pune

Social Care Workers Registration Board

Rheumatology. Opportunities in UK

I2S2 TRAINING Good Clinical Practice tips. Deirdre Thom Neonatal Nurse Coordinator

DFG. Proposal Preparation Instructions. Project Proposals. DFG form /17 page 1 of 15

Core Criteria for Education and Training Programmes

Questions and answers on the procedure of PIP compliance verification at EMA, and on paediatric rewards

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

Preliminary Questionnaire

Standard Operating Procedure INVESTIGATOR OVERSIGHT OF RESEARCH. Chief and Principal Investigators of research sponsored and/or hosted by UHBristol

Setting up a Clinical Trial

Governance %%.4- r2&% Queen s University Belfast. Standard Operating Procedure Research Governance. r2.aoc7. Research and Enterprise

STANDARD OPERATING PROCEDURE

Good Clinical Practice. Lisa de Blieck MPA CCRC Clinical Trials Coordination Center

PERFORMANCE IN INITIATING CLINICAL RESEARCH (PI) CLINICAL TRIAL ADJUSTMENT PROCESS HRA APPROVED TRIALS

Guidance for the Tripartite model Clinical Investigation Agreement for Medical Technology Industry sponsored research in NHS Hospitals managed by

Clinical Trials Assistant POSITION DESCRIPTION

12.0 Investigator Responsibilities

STANDARD OPERATING PROCEDURE SOP 220. Investigation of allegations of Research Fraud and Misconduct. NNUH UEA Joint Research Office

Why do we need an addendum to ICH E6?

GCP Training for Research Staff. Document Number: 005

Clinical Data Transparency CLINICAL STUDY REPORTS APPROACH TO PROTECTION OF PERSONAL DATA

Document Title: File Notes. Document Number: 024

Research Passport Application Form Version 3 01/09/2012

Risk Assessment and Monitoring

COMPETENCY FRAMEWORK

The GCP Perspective on Study Monitoring

Risk Assessment. Version Number 1.0 Effective Date: 21 st March Sponsored Research

Transcription:

OFFICE FOR RESEACH PROCEDURE Documentation of Investigational Site Qualifications, Adequacy of Resources and Training Records 1. Purpose: To describe the procedures related to the appropriate documentation of investigational site qualifications and training records as well as the provision of resources to perform research appropriately. 2. Scope: Applicable to all phases of clinical investigation of medicinal products, devices and diagnostics, inclusive of Industry Sponsored, Collaborative Group or Investigator Initiated trials. 3. Staff this document applies to: Principal Investigator, Associate Investigator(s), research co-coordinators and other staff involved in trial-related duties. 4. Procedure: 4.1 Documentation of Investigational Site Qualifications and Training Records The investigator(s) should: Maintain an up-to-date Curriculum vitae (CV) and review with and updated signature and date on a yearly basis Be qualified by education, training, and experience to assume responsibility for the proper conduct of the trial. This should be evidenced in the CV. Meet all the qualifications specified by the applicable regulatory requirement(s). Current medical practitioner registration details and similar documentation should be referenced in the CV. Provide evidence of such qualifications through up-to-date Curriculum vitae and/or other relevant documentation requested by the sponsor, the HREC, and/or the regulatory authority(ies). Austin Health requires that all principal investigators, associate investigators and trial coordinators of research studies hold a current TransCelerate mutually recognised good clinical practice (GCP) certification. 4 A copy of the GCP course certificate valid for 3 years from completion should be included with the research governance application. Maintain a list of appropriately qualified** persons to whom the investigator has delegated significant trial-related duties. The list is in the form of a Delegation Log and delegated latest version should be downloaded from the hub. Page 1 of 7

duties should be captured and signed and dated by the Principal Investigator on a per person basis. The delegation log may be provided by the Sponsor Company, but for Investigator Initiated studies, a separate site log should be developed (see Appendix 2). ** Appropriately qualified persons means qualified by professional qualifications, currently registered to practice in this field and operating within the delegated persons Professional Scope of Practice (eg Doctor for prescribing of study medication or Pharmacist/Clinical Research Coordinator for dispensing study medication) 4.2 Adequacy of Resources The investigator(s) should: Be able to demonstrate (if possible based on retrospective data) a potential for recruiting the required number of suitable subjects within the agreed recruitment period. This may be in the form of de-identified subject recruitment listings or other documented written evidence. Have sufficient time to properly conduct and complete the trial within the agreed trial period and have available an adequate number of qualified staff and adequate facilities for the foreseen duration of the trial to conduct the trial properly and safely. For commercially-sponsored studies the adequacy of resources is normally determined by a site feasibility assessment. Submit and receive approval of the Site Specific Assessment/Governance Application from the Office for Research prior to commencement of research at Austin Health. The Site Specific Assessment/Governance Application includes explicit resource declarations from departments involved in the planned study. 4.3 Training Records The investigator(s) should: Ensure that all persons assisting with the trial are adequately informed about the protocol, the investigational product(s), and their trial-related duties and functions. An initiation meeting must be held where all required staff are present and written evidence of study specific training is developed. Ensure that documentation of this training be kept current and available for review on request throughout the entire trial period. Ensure that tasks delegated to study staff are documented appropriately. This can be evidenced by the delegation log. However, study specific training records should be maintained to provide evidence that tasks were delegated following the correct training. Glossary Clinical Research Coordinators: A research worker who works at a clinical research site under the immediate direction of a Principal Investigator, whose research activities are conducted under Good Clinical Practice guidelines. May also be called Clinical Trial (ARCP Definition.) Coordinator or Research Coordinator. latest version should be downloaded from the hub. Page 2 of 7

Good Clinical Practice (GCP): From the International Conference on Harmonisation (ICH) guidance, GCP is a standard for the design, conduct, performance, monitoring, auditing, recording, analyses, and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity, and confidentiality of trial subjects are protected. Human Research Ethics Committee (HREC): A body which reviews research proposals involving human participants to ensure that they are ethically acceptable and in accordance with relevant standards and guidelines. The National Statement requires that all research proposals involving human participants be reviewed and approved by an HREC and sets out the requirements for the composition of an HREC. International Conference on Harmonisation (ICH) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use is a joint initiative involving both regulators and researchbased industry focusing on the technical requirements for medicinal products containing new drugs. Principal Investigator: An individual responsible for the conduct of a clinical trial at a trial site ensuring that it complies with GCP guidelines. If a trial is conducted by a team of individuals at a trial site, the investigator is the responsible leader of the team and may be called the Principal Investigator. In this instance they may delegate tasks to other team members. Associate Investigator: Any individual member of the clinical trial team designated and supervised by the investigator at a trial site to perform critical trial-related procedures and/or to make important trial-related decisions (e.g., associates, residents, research fellows). TransCelerate: TransCelerate BioPharma Inc. was launched in 2012 as a non-profit organization that collaborates across the global biopharmaceutical research and development community to identify, prioritize, design and facilitate implementation of solutions designed to drive the efficient, effective and high quality delivery of new medicines. Legislation/References/Supporting Documents: 1. Based on, and with permission of the Victorian Managed Insurance Authority VMIA GCP SOP No.001 Version:1.0 Dated 17 September 2007 2. Note for guidance on Good Clinical Practice (CPMP/ICH/135/95) annotated with TGA comments DSEB, July 2000. 3. National Statement on Ethical Conduct in Human Research, (2007). 4. http://www.transceleratebiopharmainc.com/assets/site-qualification-and-training/ latest version should be downloaded from the hub. Page 3 of 7

Appendices Appendix 1: Appendix 2: Appendix 3: Template for Signature and Delegation Log Example Training Record Form Example Curriculum Vitae Template Author/Contributors: Anne-Marie Woods, Quality Coordinator CCTC Chelsea Webster, Ethics and Research Governance Manager Authorised/Endorsed by: Dr Sianna Panagiotopoulos, Director, Office for Research Primary Person/Department Responsible for Document: Office for Research Communication Strategy: TBC latest version should be downloaded from the hub. Page 4 of 7

APPENDIX 1 : SIGNATURE LOG AND DELEGATION OF DUTIES (TEMPLATE) Protocol No: SIGNATURE LOG AND DELEGATION OF DUTIES (template) Investigator Name: Sponsor: Start Date Of Involvement Print Name Signature Sample Initials Function (e.g. sub-investigator, study nurse) Task Delegated Authorised by Investigator (initial+ date) End date of Involvement a. Informed discussion g. Investigational product accountability b. Informed consent sign off h. Randomization of subjects (e.g. IVRS) c. CRF/DCF Completion and Correction i. Essential / Regulatory documents handling d. CRF/DCF Sign-Off j. Study specific procedures e. Subject Examination/evaluation k. Other f. Investigational product dispensation circumstances. Printed versions can only be considered up-to-date for a period of one month from the printing date after which, the latest version should be downloaded from the hub. Page 5 of 7

APPENDIX 2 : INTERNAL TRAINING LOG (TEMPLATE) Section 1 Employee (Trainee) Details Name : Position / Title : Section 2 Training Details Date(s) of Training : Duration : Type : Classroom elearning Other (Provide details in Description section) Location : Description : SOP / Module /Course : (If applicable) Trainer Name : Title : Version : Section 3 Competency Assessment / Sign Off Do not sign unless you are confident you understand the implications of the training conducted. Trainee Comments Employee (Trainee) : Signature or Initials Date: / / dd/mmm/yyyy Trainer Comments (describe competency assessment if applicable) Trainer : Date: Signature or Initials Title / / dd/mmm/yyyy latest version should be downloaded from the hub. Page 6 of 7

APPENDIX 3: CURRICULM VITAE (TEMPLATE) Austin Health Investigator Curriculum Vitae First and Family Name: Present appointment: (Job Title, Department) Address Full work address including postcode Qualifications Degree and other professional qualifications ( relevant qualifications, or specify) PhD MBBS BN MSc BSc Other: Registration/licence number (if applicable) Previous appointments/ experience (include only relevant therapeutic/ practical experience after gaining qualifications) Publications ( appropriate box) (Number of articles published) 0 0 5 6-10 11-20 >20 Previous experience in clinical trials Training (accredited courses) Protocol design Recruitment Consent Data collection Data management GCP Research Ethics Research Conduct Trial procedures Other please describe below: Other please describe below: List all HREC projects that you currently hold the role of investigator (Principal and/or Associate Signature: Date: Investigator Curriculum Vitae Version 1.0, dated 02 September 2016 latest version should be downloaded from the hub. Page 7 of 7